Invention Grant
US08940737B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
有权
凋亡诱导剂用于治疗癌症和免疫和自身免疫性疾病
- Patent Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
- Patent Title (中): 凋亡诱导剂用于治疗癌症和免疫和自身免疫性疾病
-
Application No.: US13649950Application Date: 2012-10-11
-
Publication No.: US08940737B2Publication Date: 2015-01-27
- Inventor: Le Wang , George Doherty , Xilu Wang , Zhi-Fu Tao , Milan Bruncko , Aaron R. Kunzer , Michael D. Wendt , Xiaohong Song , Robin Frey , Todd M. Hansen , Gerard M. Sullivan , Andrew Judd , Andrew Souers
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicaco
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicaco
- Agency: Jone Day
- Main IPC: A61K31/54
- IPC: A61K31/54 ; A61K45/06 ; C07D417/14 ; A61K31/5377 ; A61K31/4725
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.
Public/Granted literature
- US20130096121A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Public/Granted day:2013-04-18
Information query
